These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12394139)

  • 1. How high can the standardized uptake value be?
    Hickeson M; Zhuang H; Chacko TK; Alavi A
    Clin Nucl Med; 2002 Nov; 27(11):819. PubMed ID: 12394139
    [No Abstract]   [Full Text] [Related]  

  • 2. Intense FDG uptake in a benign Hurthle cell adenoma.
    Rohren EM
    Clin Nucl Med; 2004 Oct; 29(10):664-6. PubMed ID: 15365450
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid carcinoma detected by incidental (18)F-FDG uptake in a patient with progressive cerebellar syndrome.
    Kroiss A; Uprimny C; Virgolini IJ
    Endocrine; 2016 Jan; 51(1):199-200. PubMed ID: 26077948
    [No Abstract]   [Full Text] [Related]  

  • 4. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal uptake of F-18 FDG in the sublingual gland.
    Bogsrud TV; Karantanis D; Lowe VJ
    Clin Nucl Med; 2006 Jan; 31(1):50. PubMed ID: 16374130
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.
    Petrich T; Börner AR; Otto D; Hofmann M; Knapp WH
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):641-7. PubMed ID: 11976802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake.
    Hong CM; Ahn BC; Jeong SY; Lee SW; Lee J
    Nuklearmedizin; 2013; 52(4):121-9. PubMed ID: 23928981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
    Buck AK; Glatting G; Reske SN
    J Nucl Med; 2004 Aug; 45(8):1274-6. PubMed ID: 15299047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
    Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
    Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.
    Gabriel M; Erler H; Donnemiller E; Riccabona G
    Nuklearmedizin; 2002 Apr; 41(2):N14-5. PubMed ID: 11989305
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation.
    Bural G; Torigian DA; Houseni M; Basu S; Srinivas S; Alavi A
    Hell J Nucl Med; 2009; 12(3):218-22. PubMed ID: 19936331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT1 expression in tissue and (18)F-FDG uptake.
    Avril N
    J Nucl Med; 2004 Jun; 45(6):930-2. PubMed ID: 15181126
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
    Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
    Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis.
    Basu S; Rekhi B; Shamim SA; Jambhekar NA
    Hell J Nucl Med; 2012; 15(3):252-3. PubMed ID: 23227462
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of 18F-FDG PET/CT in thyroid carcinoma.
    Muros de Fuentes MA; Mitjavila Casanovas M; Estorch Cabrera M; Lecumberri Santamaria B; Navarro González E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):186-92. PubMed ID: 26944558
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymmetric FDG uptake in a lactating breast.
    Shor M; Dave N; Reddy M; Ali A
    Clin Nucl Med; 2002 Jul; 27(7):536. PubMed ID: 12072789
    [No Abstract]   [Full Text] [Related]  

  • 19. Focal pelvic uptake in 18F-FDG PET due to a contraceptive device; a potential pitfall easily unmasked by PET-CT.
    Fuechsel FG; Weidner S; Krause T
    Nuklearmedizin; 2006; 45(4):N42-3. PubMed ID: 16969953
    [No Abstract]   [Full Text] [Related]  

  • 20. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
    Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
    Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.